Sorrento Therapeutics Stock Price, News & Analysis
SRNE
OTC Link
Company Description
Welcome to the overview page for Sorrento Therapeutics (SRNE), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
$0.0050
0.00%
0.00
Last updated: September 21, 2025 at 15:52
- %
Performance 1 year
$1.9M
551.3M
Latest News
SEC Filings
No SEC filings available for Sorrento Therapeutics.
Financial Highlights
$62,839,000
Revenue (TTM)
-$577,757,000
Net Income (TTM)
-$1.37
-$293,857,000
Operating Cash Flow
-919.42%
-802.55%
Upcoming Events
Short Interest History
Last 12 Months
Loading short interest data...
Days to Cover History
Last 12 Months
Loading days to cover data...
Frequently Asked Questions
What is the current stock price of Sorrento Therapeutics (SRNE)?
The current stock price of Sorrento Therapeutics (SRNE) is $0.005 as of September 19, 2025.
What is the market cap of Sorrento Therapeutics (SRNE)?
The market cap of Sorrento Therapeutics (SRNE) is approximately 1.9M. Learn more about what market capitalization means.
What is the revenue (TTM) of Sorrento Therapeutics (SRNE) stock?
The trailing twelve months (TTM) revenue of Sorrento Therapeutics (SRNE) is $62,839,000.
What is the net income of Sorrento Therapeutics (SRNE)?
The trailing twelve months (TTM) net income of Sorrento Therapeutics (SRNE) is -$577,757,000.
What is the earnings per share (EPS) of Sorrento Therapeutics (SRNE)?
The diluted earnings per share (EPS) of Sorrento Therapeutics (SRNE) is -$1.37 on a trailing twelve months (TTM) basis. Learn more about EPS.
What is the operating cash flow of Sorrento Therapeutics (SRNE)?
The operating cash flow of Sorrento Therapeutics (SRNE) is -$293,857,000. Learn about cash flow.
What is the profit margin of Sorrento Therapeutics (SRNE)?
The net profit margin of Sorrento Therapeutics (SRNE) is -919.42%. Learn about profit margins.
What is the operating margin of Sorrento Therapeutics (SRNE)?
The operating profit margin of Sorrento Therapeutics (SRNE) is -802.55%. Learn about operating margins.
What is the current ratio of Sorrento Therapeutics (SRNE)?
The current ratio of Sorrento Therapeutics (SRNE) is 0.29, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.
What is the operating income of Sorrento Therapeutics (SRNE)?
The operating income of Sorrento Therapeutics (SRNE) is -$504,315,000. Learn about operating income.